What if your biggest problem isn’t burnout, but how you recover? Performance coach Andrew May turns the spotlight back on doctors themselves, challenging the gap between what you tell patients and what you do in your own life.
Malnutrition is frequently under recognised and under treated in routine clinical practice. With up to two-thirds of community-dwelling older Australians at risk, proactive screening and intervention are essential to target modifiable factors.
Anyone born after January 1 2009 will never be able to legally buy tobacco in the UK thanks to the tobacco and vapes bill, which is expected to become law in March 2026.
Dr Marita Long talks with physiotherapist Alison Slater about viewing common midlife and older-patient musculoskeletal complaints through a different – and often overlooked – lens.
Dr Josephine Braid discusses setting healthy boundaries in clinical practice. Explore why boundaries can be dificult for doctors, how they show up in everyday consultations, and why protecting your own sustainability is essential for long‑term patient care.
Physiotherapist Alison Slater reveals why fascia, a dynamic, innervated system is key to understanding movement, chronic pain, and patient care, challenging traditional musculoskeletal paradigms and offering practical insights for clinicians.
For years, scientists have known that moving our bodies can sharpen our minds. Physical activity boosts blood flow to the brain, enhances neuroplasticity and reduces chronic inflammation. These processes are believed to protect against cognitive decline, including dementia.
The SURMOUNT-5 trial has provided definitive evidence that tirzepatide is superior to semaglutide for obesity treatment, achieving an additional 6.5% body weight reduction and nearly doubling the proportion of patients who lose 25% or more of their body weight.
With obesity demonstrating mortality rates comparable to cigarette smoking and obstructive sleep apnoea (OSA) potentially affecting up to one billion people worldwide, the intersection of these conditions demands innovative therapeutic approaches.
Recent advances in incretin-based therapies, particularly the GLP-1/GIP receptor agonist tirzepatide (Mounjaro), are revolutionising treatment for patients with concurrent obesity and OSA, offering clinically significant improvements that may challenge traditional CPAP-centric management strategies.
Tune in for "Facial rashes case studies - Practical guide to assessment and management" lecture
Tuesday 9th June, 7pm - 9pm AEST
Speaker
Dr Philip Tong
Consultant Dermatologist; Founder, DermScreen, Dermatology Junction; Visiting Medical Officer, St Vincent’s Hospital Sydney
What does it mean when a facial red rash does not respond to topical steroids and gets worse with the treatment? Dermatologist Dr Philip Tong presents a series of cases with this scenario.